Medications approved for dementia in Canada

There are no treatments today that can cure irreversible types of dementia. However, there are currently four medications, approved by Health Canada, that can help manage symptoms. Learn about them on this page.

Doctor talking to patient

What medications are available?

Medications now approved in Canada for dementia may help with symptoms such as changes in language, thinking abilities and movement.

Each medication has a brand name and a generic name.

  • Aricept™ (brand name) or Donepezil (generic name)
  • Reminyl ER™ (brand name) or Galantamine (generic name)
  • Exelon™ (brand name) or Rivastigmine (generic name)
  • Ebixa® (brand name) or Memantine (generic name)

It doesn't matter whether the medication is brand name or generic – their effects are the same.

Depending on how severe your symptoms are and how quickly the disease progresses, different medications may be appropriate.

Cholinesterase inhibitors (donepezil, galantamine and rivastigmine) were originally developed to treat only Alzheimer’s disease, not for other types of dementia and similar conditions such as mild cognitive impairment (MCI).

However, cholinesterase inhibitors are generally used to treat all types of dementia, except for frontotemporal dementia. However, each type of dementia may have specific recommendations, so be sure to check with your health-care provider.

Medications for mild to moderate Alzheimer's:

  • Donepezil (Aricept™)
  • Galantamine (Reminyl™)
  • Rivastigmine (Exelon™)

Medications for moderate to advanced Alzheimer's disease:

  • Memantine (Ebixa®)
  • Donepezil (Aricept™)

Medications for Lewy body dementia:

  • Donepezil (Aricept™)
  • Reminyl ER® (also known as galantamine)
  • Rivastigmine (Exelon™)
  • Memantine (Ebixa®)

Medications for Parkinson disease dementia:

  • Rivastigmine (Exelon™)

More information to know:

  • There is not enough evidence that supports the use of cholinesterase inhibitors or memantine in people living with vascular dementia or frontotemporal dementia.
  • However, for people with a combination of Alzheimer’s disease and vascular dementia (known as mixed dementia), cholinesterase inhibitors may be used when Alzheimer’s disease is the main cause, but not to treat vascular dementia on its own.
  • In the case of MCI, these medications are generally not effective. They do not reduce the risk of MCI progressing to Alzheimer’s disease or another type of dementia.

Important to know:

Dementia affects each person differently. A treatment that works for one person may not work for someone else.

How do these medications work?

Three medications can help prevent decline in learning and memory

Three of the medications – donepezil (Aricept™), galantamine (Reminyl™) and rivastigmine (Exelon™) – are cholinesterease inhibitors. These medications are can prevent the breakdown of a brain chemical called acetylcholine.

Understand more about acetylcholine:

  • Acetylcholine is a chemical in the brain thought to be important for learning and memory.
  • For example, a person with Alzheimer’s disease has lower levels of acetylcholine than someone without the disease.
  • By providing an increased concentration of acetylcholine, these medications may temporarily ease or stabilize some of the symptoms of most types of dementia.

These medications may be helpful for two to three years, possibly longer. Eventually, the nerve endings die and the medications are no longer effective. Because of that, they are only useful for people in the mild to moderate stages of dementia.

One medication can protect your brain cells

The other medication, memantine (Ebixa®), is an NMDA receptor antagonist. This medication is thought to work by affecting another brain chemical called glutamateFor example, when a person has Alzheimer’s disease, glutamate stimulates this receptor too much. This causes the nerve cells to become damaged. However, NMDA receptors help stop this from happening.

Understand more about glutamate:

  • Glutamate helps send messages between brain cells.
  • Glutamate is released in excessive amounts when brain cells are damaged by Alzheimer’s disease.
  • Memantine may protect brain cells by blocking effects of too much glutamate.

Memantine can be prescribed for people in the middle and late stages who can’t tolerate the side effects from a cholinesterase inhibitor.

Some specialists recommend using cholinesterase inhibitors and memantine (Ebixa®) together. However, more and larger clinical trials are needed to confirm these results.

Please refer to our downloadable brochure for more information specific to Alzheimer's disease: Medications for Alzheimer’s disease: are they right for you?

How can you tell if a medication is helping or hurting?

Potential improvements

Improvements are often subtle and can be hard to detect, even for your doctor or pharmacist. It also may take several months to see the benefits. Some people will benefit more than others.

Improvements may include:

  • Modest cognitive changes: For example, the person living with Alzheimer's disease notices improvements in memory, concentration and language.
  • Subtle behavioural changes: For example, the person living with Alzheimer's disease is calmer, more engaged in daily activities (such as cooking, bathing and using appliances), more motivated and more communicative.

Some people will not show significant improvement, but they may stabilize for a period of time.

Potential side effects

Medications are usually started at the lowest dose available, which may help minimize side effects. If the person is tolerating the medication, the dosage is usually increased slowly to maximize the benefits of the treatment. To get a full list of side effects, ask your health-care provider.

If any of these side effects are experienced, contact your doctor or pharmacist as soon as possible.

Some side effects of donepezil, galantamine and rivastigmine:

  • Gastrointestinal side effects, like nausea, vomiting, diarrhea or loose stools
  • Loss of appetite and subsequent unintended weight loss
  • Slowing of heart rate
  • Dizziness
  • Falls
  • Headaches
  • Nightmares
  • Sleep disruptions
  • Note: You may experience insomnia or sleep disruptions depending on the time of day you take this medication. For instance, some experts recommend taking donepezil (Aricept) in the morning for this reason. This is so it won't disrupt sleep for some users at night. Discuss what's best for you with your doctor and pharmacist.

Some side effects of memantine:

  • Sedation
  • Muscle cramps
  • Headaches
  • Dizziness
  • Fatigue
  • Insomnia
  • Note: As for the other medications listed above, be aware sleep disruptions can be side effects for some. Make sure to discuss any sleep issues and medication interactions or timings with your doctor and pharmacist.

Caution is also required in prescribing memantine for people who have problems with their kidneys.

No changes

Because Alzheimer’s disease is a progressive disease that gets worse over time, along with many other types of dementia, noticing no changes in the person’s daily function and behaviour for six months or a year after starting the drug is a positive outcome and a sign that the medication is working.

If the medications are discontinued, the person may lose the benefits and might decline at a rate faster than otherwise expected.

When should you start taking these medications?

If there are no other health conditions that could make taking these medications dangerous for you, doctors generally recommend starting a trial of one of these medications immediately after diagnosis.

If your doctor is uncomfortable or reluctant to prescribe one of these medications, consider requesting a consultation with a geriatric specialist for another opinion.

For how long should these medications be taken?

If you are benefiting from the medication and can tolerate the side effects, it's often recommended that you continue taking the medication until the final stages.

In other cases, where there is no clear benefit, if there is a safety concern, the side effects are too difficult, or you may just dislike taking the medication, then it may be time to stop treatment. Each experience is unique – consult your doctor to decide what's best.

Are these medications covered by your provincial health insurance plan?

Medication coverage varies from province to province and individuals may be required to cover some of the costs associated with these medications.

The person must meet specific criteria in their province or territory to be entitled to have the medications paid for by their regional medical coverage plan. Check with your region's health plan to find out if you have coverage.

Medication may also be covered by many private insurance plans.

What other treatment options are available?

Medications should only be one part of your overall care. Consider your treatment options:

  • Some alternative treatments (such as music therapy, aromatherapy, pet therapy, and massage) may be beneficial to people with dementia. However, the lack of evidence supported by research prevents us from determining their effectiveness.
  • There are potential treatments that may be effective in treating not just the symptoms of dementia, but perhaps even stop cognitive decline outright. However, plenty of research and testing needs to be done to validate their results. We may still be years away from seeing these new treatments become available to the public.
  • The most effective treatment that doesn't involve medication? Follow a brain-healthy lifestyle. Taking part in physical and social activities, challenging your brain and making healthy choices are vital to living well with dementia.

For a full list of treatment options currently available to you, please read our print-friendly brochure.

Now that you know the accurate information and realistic expectations about the potential benefits and possible side effects of these medications, talk with your doctor or pharmacist about whether these medications are right for you.

More useful links and resources

Medications for Alzheimer’s disease: Are they right for you? Alzheimer Society of Canada. Get all the information you need on the current medications approved to treat the symptoms of Alzheimer's disease, including their potential benefits and risks.

What is aducanumab? Alzheimer Society of Canada. This information page summarizes information about a drug that was conditionally approved for use in the United States in June 2021. A European Union agency refused the drug in December 2021. Drug-maker Biogen withdrew the drug from Health Canada review in June 2022.

[Updated] Your questions, answered: What should Canadians know about lecanemab’s full U.S. FDA approval? Alzheimer Society of Canada. This webpage provides the latest updates about the drug, lecanemab, which has been approved in the United States.

Your questions, answered: What should Canadians know about donanemab’s full trial results release? Alzheimer Society of Canada. In July 2023, American drug company Eli Lilly and Company released full results from a Phase 3 trial of donanemab, a drug that aims to target Alzheimer’s disease. This webpage is information that people in Canada may want to know about this.

Drug approval process for the treatment of Alzheimer’s disease. Alzheimer Society of Canada. Get the full picture of how a drug gets approved for public use in Canada, including a list of the currently approved medications that can treat the symptoms of Alzheimer's disease.

Treatment options. Alzheimer Society of Canada. This downloadable brochure gives an overview of all the treatment options for dementia that are available to you.

Canada's provincial health plans. Special Benefits Insurance Services. This page is a helpful summary of the covered healthcare services in each province, with links to each plan on each respective province's government website.

Last updated: May 30, 2024